Literature DB >> 27699625

Cannabinoids and GI Disorders: Endogenous and Exogenous.

Zachary Wilmer Reichenbach1,2, Ron Schey3.   

Abstract

OPINION STATEMENT: Despite the political and social controversy affiliated with it, the medical community must come to the realization that cannabinoids exist as a ubiquitous signaling system in many organ systems. Our understanding of cannabinoids and how they relate not only to homeostasis but also in disease states must be furthered through research, both clinically and in the laboratory. The identification of the cannabinoid receptors in the early 1990s have provided us with the perfect target of translational research. Already, much has been done with cannabinoids and the nervous system. Here, we explore the implications it has for the gastrointestinal tract. Most therapeutics currently on the market presently target only one aspect of the cannabinoid system. Our main purpose here is to highlight areas of research and potential avenues of discovery that the cannabinoid system has yet to reveal.

Entities:  

Keywords:  CB1 receptor; CB2 receptor; Cannabinoids; GI motility; GPR55; Irritable bowel syndrome (IBS); Visceral hypersensitivity

Year:  2016        PMID: 27699625     DOI: 10.1007/s11938-016-0111-1

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  122 in total

1.  Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs.

Authors:  Anders Lehmann; L Ashley Blackshaw; Lena Brändén; Anita Carlsson; Jörgen Jensen; Emelie Nygren; Scott D Smid
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

Review 2.  The gastrointestinal pharmacology of cannabinoids: focus on motility.

Authors:  Raquel Abalo; Gema Vera; Ana Esther López-Pérez; María Martínez-Villaluenga; María Isabel Martín-Fontelles
Journal:  Pharmacology       Date:  2012-06-14       Impact factor: 2.547

Review 3.  Evidence for novel cannabinoid receptors.

Authors:  Malcolm Begg; Pál Pacher; Sándor Bátkai; Douglas Osei-Hyiaman; László Offertáler; Fong Ming Mo; Jie Liu; George Kunos
Journal:  Pharmacol Ther       Date:  2005-01-11       Impact factor: 12.310

4.  Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.

Authors:  Christel Rousseaux; Xavier Thuru; Agathe Gelot; Nicolas Barnich; Christel Neut; Laurent Dubuquoy; Caroline Dubuquoy; Emilie Merour; Karen Geboes; Mathias Chamaillard; Arthur Ouwehand; Greg Leyer; Didier Carcano; Jean-Frédéric Colombel; Denis Ardid; Pierre Desreumaux
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

5.  The endogenous cannabinoid system protects against colonic inflammation.

Authors:  Federico Massa; Giovanni Marsicano; Heike Hermann; Astrid Cannich; Krisztina Monory; Benjamin F Cravatt; Gian-Luca Ferri; Andrei Sibaev; Martin Storr; Beat Lutz
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 6.  Epidemiology and mechanisms of gastroesophageal reflux disease in the elderly: a perspective.

Authors:  Mohammad Bashashati; Irene Sarosiek; Richard W McCallum
Journal:  Ann N Y Acad Sci       Date:  2016-08-15       Impact factor: 5.691

7.  Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity.

Authors:  Akira Kikuchi; Katsuyo Ohashi; Yutaka Sugie; Hiromi Sugimoto; Hirofumi Omura
Journal:  J Pharmacol Sci       Date:  2008-02-09       Impact factor: 3.337

Review 8.  Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.

Authors:  F C Machado Rocha; S C Stéfano; R De Cássia Haiek; L M Q Rosa Oliveira; D X Da Silveira
Journal:  Eur J Cancer Care (Engl)       Date:  2008-07-09       Impact factor: 2.520

9.  CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.

Authors:  Astrid Cannich; Carsten T Wotjak; Kornelia Kamprath; Heike Hermann; Beat Lutz; Giovanni Marsicano
Journal:  Learn Mem       Date:  2004 Sep-Oct       Impact factor: 2.460

Review 10.  GPR55 - a putative "type 3" cannabinoid receptor in inflammation.

Authors:  Hyewon Yang; Juan Zhou; Christian Lehmann
Journal:  J Basic Clin Physiol Pharmacol       Date:  2016-05-01
View more
  1 in total

Review 1.  Endocannabinoid-related compounds in gastrointestinal diseases.

Authors:  Marcella Pesce; Alessandra D'Alessandro; Osvaldo Borrelli; Stefano Gigli; Luisa Seguella; Rosario Cuomo; Giuseppe Esposito; Giovanni Sarnelli
Journal:  J Cell Mol Med       Date:  2017-10-09       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.